Authors: LABS KH LABS R ROSSNER M

Citation: Kh. Labs et al., CLINICAL-EXPERIENCE WITH PENTOXIFYLLINE, Atherosclerosis, 131, 1997, pp. 37-39

Authors: BRANDSTATTER G MARKS IN LANZA F KOGUT D COBERT B SAVITSKY JP BENDER W LABS R WURZER H

Citation: G. Brandstatter et al., A MULTICENTER, RANDOMIZED, DOUBLE-BLIND COMPARISON OF ROXATIDINE WITHRANITIDINE IN THE TREATMENT OF PATIENTS WITH UNCOMPLICATED BENIGN GASTRIC-ULCER DISEASE, Clinical therapeutics, 17(3), 1995, pp. 467-478

Authors: RUBINSTEIN E LABS R REEVES A

Citation: E. Rubinstein et al., A REVIEW OF THE ADVERSE EVENTS PROFILE OF CEFPIROME, Drug safety, 9(5), 1993, pp. 340-345